Risk assessment of dietary exposures to compounds that are genotoxic and carcinogenic--an overview.

The process of risk assessment of dietary exposures to genotoxic carcinogens is summarised. Exposures to six genotoxic carcinogens in food (acrylamide, aflatoxin B1, benzo(a)pyrene, dimethylnitrosamine, ethyl carbamate, PhIP) have been used to illustrate the process. The margin of exposure (MOE) approach is seen as a useful method to be used in the risk characterisation step of assessing exposures to genotoxic carcinogens. This approach combines information on animal potency and human exposure, and can be used to indicate levels of concern and also the ranking between various exposures to such agents. Both the T25 and the BMDL10 methods may be used as a reference point. Should a specific MOE value be developed as a cut-off between levels of concern and levels of low concern, the value using T25 data is proposed to be 2.5-times higher than using BMDL10 data. Linear low-dose extrapolation using either T25 or BMDL10, may also be applied. However, it should be understood that this approach should not be interpreted as giving a precise estimate of human risk. For exposures to mutagens in food lacking carcinogenicity data, it is proposed to apply the MOE approach to the lowest effective dose (LED) for in vivo genotoxicity.

[1]  Muller Jja,et al.  Tumorigenic effects in Wistar rats orally administered benzo[a] pyrene for two years (gavage studies). Implications for human cancer risks associated with oral exposure to polycyclic aromatic hydrocarbons , 2002 .

[2]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[3]  J. Gray,et al.  Genome changes and gene expression in human solid tumors. , 2000, Carcinogenesis.

[4]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[5]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[6]  G. Williams,et al.  DNA reactive and epigenetic carcinogens. , 1992, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[7]  Gary M Williams,et al.  DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard , 2005, Critical reviews in toxicology.

[8]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[9]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[10]  G. Wogan,et al.  Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. , 1974, Food and cosmetics toxicology.

[11]  Lutz Edler,et al.  Food safety in Europe (FOSIE): risk assessment of chemicals in food and diet , 2002 .

[12]  Division on Earth.  Risk Assessment in the Federal Government: Managing the Process , 1983 .

[13]  K. Loeb,et al.  Significance of multiple mutations in cancer. , 2000, Carcinogenesis.

[14]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .

[15]  Keith A. Johnson,et al.  Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. , 1986, Toxicology and applied pharmacology.

[16]  D W Gaylor,et al.  NEW ISSUES IN CANCER RISK ASSESSMENT , 2000, Drug metabolism reviews.

[17]  E Dybing,et al.  T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity. , 1997, Pharmacology & toxicology.

[18]  E. Dybing,et al.  Comparison of carcinogenic and in vivo genotoxic potency estimates. , 2005, Basic & clinical pharmacology & toxicology.

[19]  A G Renwick,et al.  Hazard characterisation of chemicals in food and diet. dose response, mechanisms and extrapolation issues. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  A. Sarasin,et al.  The genetics of the hereditary xeroderma pigmentosum syndrome. , 2002, Biochimie.

[21]  W Slob,et al.  Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  B. Dunn.  Wide-range linear dose-response curve for DNA binding of orally administered benzo(a)pyrene in mice. , 1983, Cancer research.

[23]  J. Swenberg,et al.  O4-ethyldeoxythymidine, but not O6-ethyldeoxyguanosine, accumulates in hepatocyte DNA of rats exposed continuously to diethylnitrosamine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N Ito,et al.  Dose-dependence of 2-amino-1-methy1–6-phenylimidazo[4, 5-b]-pyridine (PhIP) carcinogenicity in rats , 1993 .

[25]  P Grasso,et al.  Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. , 1991, Cancer research.

[26]  G. Williams,et al.  Risk assessment of DNA-reactive carcinogens in food. , 2005, Toxicology and applied pharmacology.

[27]  P Grasso,et al.  Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. , 1991, Cancer research.

[28]  W. Lutz,et al.  Quantitative evaluation of DNA-binding data in vivo for low-dose extrapolations. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[29]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.

[30]  I. Hertz-Picciotto,et al.  Risk characterisation of chemicals in food and diet. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  Martha M Moore,et al.  Use of genetic toxicology information for risk assessment , 2005, Environmental and molecular mutagenesis.

[32]  Lutz Edler,et al.  Risk assessment of substances that are both genotoxic and carcinogenic: Report of an International Conference organized by EFSA and WHO with support of ILSI Europe , 2006 .

[33]  M. Thun,et al.  American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity , 2002, CA: a cancer journal for clinicians.

[34]  T. Key,et al.  The effect of diet on risk of cancer , 2002, The Lancet.

[35]  A. Sarasin,et al.  An overview of the mechanisms of mutagenesis and carcinogenesis. , 2003, Mutation research.

[36]  J Kleiner,et al.  Assessment of intake from the diet. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[37]  J W Bridges,et al.  Hazard identification by methods of animal-based toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  J. Cowell,et al.  Tumour suppressor genes. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  Harald Enzmann,et al.  Principles of Testing for Carcinogenic Activity , 2007 .

[40]  D. Jonker,et al.  The benchmark approach applied to a 28-day toxicity study with Rhodorsil Silane in rats. the impact of increasing the number of dose groups. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[41]  E Dybing,et al.  Risk assessment of acrylamide in foods. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  J Schlatter,et al.  Ethyl carbamate: analytical methodology, occurrence, formation, biological activity and risk assessment. , 1991, Mutation research.

[43]  A G Renwick,et al.  Structure-based thresholds of toxicological concern--guidance for application to substances present at low levels in the diet. , 2005, Toxicology and applied pharmacology.

[44]  G. B. Gori,et al.  Contribution of the environment to cancer incidence: an epidemiologic exercise. , 1977, Journal of the National Cancer Institute.

[45]  Neumann Hg.  Dose-response relationship in the primary lesion of strong electrophilic carcinogens. , 1980 .

[46]  L. Ellwein,et al.  Cell proliferation in carcinogenesis. , 1990, Science.

[47]  E D Kroese,et al.  A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25. , 2001, Pharmacology & toxicology.

[48]  Malcolm C. Pike,et al.  The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984 .

[49]  W. Lutz.  Dose-response relationship and low dose extrapolatioin in chemical carcinogenesis , 1990 .

[50]  E. Dybing,et al.  Comparison of carcinogen hazard characterisation based on animal studies and epidemiology. , 2005, Basic & clinical pharmacology & toxicology.

[51]  J Schlatter,et al.  Chemical carcinogens and overnutrition in diet-related cancer. , 1992, Carcinogenesis.

[52]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .